$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Drug delivery system utilizing thermosetting gels 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/415
  • A61K-031/435
  • A61K-031/19
  • A61K-031/66
  • A61K-031/74
  • A61K-031/70
  • A61K-031/135
  • A61K-031/54
출원번호 US-0495240 (1983-05-16)
발명자 / 주소
  • Haslam John L. (Lawrence KS) Higuchi Takeru (Lawrence KS) Mlodozeniec Arthur R. (Lawrence KS)
출원인 / 주소
  • Merck & Co., Inc. (Rahway NJ 02)
인용정보 피인용 횟수 : 167  인용 특허 : 1

초록

Present invention provides a unique drug delivery device for delivering drug by injection into a body. The drug delivery system comprises the drug and polymer which is a liquid at room temperature and a semi-solid or gel at the body temperature.

대표청구항

An aqueous pharmaceutical composition for injection into a body to treat a condition requiring pharmacological treatment comprising a. 10% to 50% by weight of a polymer of the formula [Figure] wherein w is an integer of from 2 to 6 containing approximately 40% to 80% poly(oxyethylene) and approximat

이 특허에 인용된 특허 (1)

  1. Krezanoski Joseph Z. (Los Altos CA), Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery t.

이 특허를 인용한 특허 (167)

  1. Hood, John; KC, Sunil Kumar; Wallace, David Mark, 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof.
  2. Hood, John; Kumar K C, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof.
  3. Hood, John; Kumar KC, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof.
  4. Hood, John; Kumar KC, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof.
  5. Hood, John; Kumar KC, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof.
  6. Hood, John; Kumar KC, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof.
  7. Hood, John; K C, Sunil Kumar; Wallace, David Mark, 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof.
  8. Hood, John; KC, Sunil Kumar; Wallace, David Mark, 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof.
  9. Hood, John; KC, Sunil Kumar; Wallace, David Mark, 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof.
  10. Hood, John; Kumar KC, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof.
  11. Hood, John; Kumar KC, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof.
  12. Hood, John; Kumar KC, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof.
  13. Hood, John; Kumar KC, Sunil; Wallace, David Mark, 1H-pyrazolo[3,4-β]pyridines and therapeutic uses thereof.
  14. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof.
  15. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof.
  16. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 2-(1H-indazol-3-yl)-3H-imidazo[4,5-B]pyridine and therapeutic uses thereof.
  17. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof.
  18. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-benzo[D]imidazol-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof.
  19. Kc, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-imidazo[4,5-C]pyridin-2-YL)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof.
  20. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof.
  21. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof.
  22. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Marakovits, Joseph Timothy; Bollu, Venkataiah; Hood, John, 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof.
  23. Kc, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-imidazo[4,5-c]pyridin-2-yl)-1H-pyrazolo[3,4-b]pyridine and therapeutic uses thereof.
  24. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof.
  25. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof.
  26. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof.
  27. Kc, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof.
  28. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof.
  29. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof.
  30. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof.
  31. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereof.
  32. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof.
  33. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof.
  34. K C, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof.
  35. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Marakovits, Joseph Timothy; Bollu, Venkataiah; Hood, John, 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof.
  36. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof.
  37. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof.
  38. KC, Sunil Kumar; Wallace, David Mark; Cao, Jianguo; Chiruta, Chandramouli; Hood, John, 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof.
  39. K C, Sunil Kumar; Hood, John, 3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof.
  40. Kumar KC, Sunil; Hood, John, 3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof.
  41. Hood, John; Kumar KC, Sunil; Wallace, David Mark; Mittapalli, Gopi Kumar; Hofilena, Brian Joseph; Mak, Chi Ching; Bollu, Venkataiah; Eastman, Brian, 5-substituted indazole-3-carboxamides and preparation and use thereof.
  42. Paul, Marlene L.; Lowery, Michael D.; Brady, Daniel G.; Gwon, Arlene, Accommodating intraocular lens and method of manufacture thereof.
  43. Paul, Marlene L.; Lowery, Michael D.; Brady, Daniel; Gwon, Arlene, Accommodating intraocular lens and method of manufacture thereof.
  44. Brady, Daniel G.; Lowery, Michael D; Paul, Marlene L; Laguette, Stephen W; Glick, Robert E, Accommodating intraocular lens with outer support structure.
  45. Bumbalough, Timothy R., Accommodating intraocular lenses.
  46. Bumbalough, Timothy; Jain, Rakhi; Catlin, Scott J.; Yorita, Tamara J., Accommodating intraocular lenses.
  47. Takeuchi Masanobu (Tokyo JPX) Suzuki Hiroe (Tokyo JPX) Takahashi Toshie (Tokyo JPX) Maruyama Hiroki (Tokyo JPX) Fukushima Miyako (Tokyo JPX) Naitou Keiko (Tokyo JPX) Oguma Touru (Tokyo JPX) Goto Masa, Aqueous drug composition having property of reversible thermosetting gelation.
  48. Dacquay, Bruno; Lind, Casey; Dos Santos, Cesario; Hallen, Paul R., Battery operated surgical hand piece with disposable end.
  49. Yu, Ya-Jen; Chen, Chin-Fu; Lin, Tsai-Yu; Yeh, Shao-Jen; Wang, Shian-Yih; Lai, Po-Liang, Biodegradable copolymer and thermosensitive material.
  50. Yu, Ya-Jen; Chen, Chin-Fu; Lin, Tsai-Yu; Yeh, Shao-Jen; Wang, Shian-Yih; Lai, Po-Liang, Biodegradable copolymer and thermosensitive material.
  51. Kiser, Patrick F.; Thomas, Allen A., Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments.
  52. Masters, David B.; Berg, Eric Peter, Biomatrix structural containment and fixation systems and methods of use thereof.
  53. Tacey X. Viegas ; Lorraine E. Reeve ; Raymond L. Henry, Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels.
  54. O'Malley, Bert W.; Li, Daqing; Paulson, David, Chitosan-based matrices and uses thereof.
  55. Lee, Raphael C.; Kuo, Annie; Hyldkrog, Hanne Gissel; Despa, Florin; Mustafi, Devkumar, Compositions and methods for refolding of denatured proteins.
  56. Lee, Raphael C; Kuo, Annie; Hyldkrog, Hanne Gissel; Despa, Florin; Mustafi, Devkumar, Compositions and methods for refolding of denatured proteins.
  57. Kabanov Alexander V. ; Alakhov Valery Yu.,CAX ; Chekhonin Vladimir P.,RUX ; Batrakova Elena V.,RUX ; Kabanov Victor A.,RUX, Compositions for targeting biological agents.
  58. Dobrozsi, Douglas Joseph; Hayes, II, Jerry William; Desai, Kishor Jivanlal; Robbins, Brian James, Compositions having improved delivery of actives.
  59. Kabanov Alexander V. ; Alakhov Valery Y.,CAX ; Batrakova Elena V., Copolymer compositions for oral delivery.
  60. Oxman, Joel D.; Mitra, Sumita B., Delivery of hydrogel compositions as a fine mist.
  61. Trom, Matthew C.; Oxman, Joel D., Dental compositions.
  62. Trom, Matthew C.; Oxman, Joel D., Dental compositions.
  63. Dacquay, Bruno; Dos Santos, Cesario; Foster, James; Sanchez, Robert, Disposable ophthalmic injection device.
  64. Santos, Cesario Dos; Pinedjian, Raffi; Sanchez, Robert; Dacquay, Bruno; Lind, Casey, Drug casting.
  65. David B. Masters, Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices.
  66. Illum Lisbeth (Charlottenlund DKX), Drug delivery system.
  67. Sanchez, Robert; Foster, James; Dos Santos, Cesario, Dual thermal coefficient dispensing chamber.
  68. Pinedjian, Raffi, Easy cleaning C-shaped charging base.
  69. Masters, David B.; Berg, Eric P., Encapsulated or coated stent systems.
  70. Ron Eyal S. ; Bromberg Lev ; Temchenko Marina, End modified thermal responsive hydrogels.
  71. Ron,Eyal S.; Bromberg,Lev; Temchenko,Marina, End modified thermal responsive hydrogels.
  72. Gehrke Steven Henry (Cincinnati OH) Lupton E. C. (Boston MA) Schiller Matthew E. (Waltham MA) Uhden Lorelle (Cincinnati OH) Vaid Nitin (Kanpur INX), Enhanced loading of solutes into polymer gels and methods of use.
  73. Kadziauskas, Kenneth E.; Reisin, Carina R.; Bumbalough, Timothy R., Fixation of ophthalmic implants.
  74. Lobl, Thomas J.; Nagy, Anna Imola; Pananen, Jacob E.; Schloss, John V., Flow-induced delivery from a drug mass.
  75. Hood, John; KC, Sunil Kumar; Kibar, Osman; Barroga, Charlene F., Gamma-diketones for treatment and prevention of aging skin and wrinkles.
  76. Cohen Jonathan M. (Matawan NJ) Berry Ira R. (Westfield NJ) Borkan Lionel (New Vernon NJ), Gelatin-encapsulated controlled-release composition.
  77. Barbara H. O'Connor ; James Q. Oeswein, Human growth hormone aqueous formulation.
  78. O'Connor Barbara H. ; Oeswein James Q., Human growth hormone aqueous formulation.
  79. Canelli, Hugh B.; Chandrakant, Partha; Chon, James Y.; Sorensen, Gary P.; Wilson, Daniel J.; Gordon, Raphael, Hydraulic injector and methods for intra-ocular lens insertion.
  80. Hood, John; Wallace, David Mark; KC, Sunil Kumar, Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof.
  81. Hood, John; Wallace, David Mark; KC, Sunil Kumar, Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof.
  82. Hood, John; Wallace, David Mark; Kc, Sunil Kumar, Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof.
  83. Hood, John; Wallace, David Mark; Kumar KC, Sunil, Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof.
  84. Hood, John; Wallace, David Mark; Kumar KC, Sunil, Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof.
  85. Hood, John; Wallace, David Mark; Kc, Sunil Kumar, Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof.
  86. Hood, John; Wallace, David Mark; Kumar KC, Sunil, Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof.
  87. Hood, John; Wallace, David Mark; Kumar KC, Sunil, Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof.
  88. Hood, John; Wallace, David Mark; Kumar KC, Sunil, Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof.
  89. Hood, John; Wallace, David Mark; Kumar KC, Sunil, Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof.
  90. Hood, John; Wallace, David Mark; Kumar KC, Sunil, Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof.
  91. Hood, John; Wallace, David Mark; Kumar KC, Sunil, Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof.
  92. Hood, John; Wallace, David Mark; KC, Sunil Kumar, Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof.
  93. Hood, John; Kumar KC, Sunil, Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitors.
  94. Hood, John; Kc, Sunil Kumar, Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors.
  95. Hood, John; Kumar KC, Sunil, Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors.
  96. Bonassar, Lawrence J.; Rowley, Jon A.; Mooney, David J., Injection molding of living tissues.
  97. Bumbalough, Timothy R, Intraocular lens and methods for providing accommodative vision.
  98. Bumbalough, Timothy R., Intraocular lens having a haptic that includes a cap.
  99. Woods, Randall, Intraocular lens implant having posterior bendable optic.
  100. Vacanti,Charles A.; Vacanti,Martin P., Isolation of spore-like cells from tissues exposed to extreme conditions.
  101. KC, Sunil Kumar; Mak, Chi Ching; Eastman, Brian Walter; Cao, Jianguo; Bollu, Venkataiah; Mittapalli, Gopi Kumar; Chiruta, Chandramouli, Isoquinolin-3-yl carboxamides and preparation and use thereof.
  102. KC, Sunil Kumar; Mak, Chi Ching; Eastman, Brian Walter; Cao, Jianguo; Bollu, Venkataiah; Mittapalli, Gopi Kumar; Chiruta, Chandramouli, Isoquinolin-3-yl carboxamides and preparation and use thereof.
  103. KC, Sunil Kumar; Mak, Chi Ching; Eastman, Brian Walter; Cao, Jianguo; Bollu, Venkataiah; Mittapalli, Gopi Kumar; Chiruta, Chandramouli, Isoquinolin-3-yl carboxamides and preparation and use thereof.
  104. Slepian Marvin J. ; Massia Stephen P., Local polymeric gel cellular therapy.
  105. Viegas Tacey X. (Canton MI) Reeve Lorraine E. (Dexter MI) Henry Raymond L. (Grosse Pointe Woods MI), Medical uses of in situ formed gels.
  106. Viegas Tacey X. ; Reeve Lorraine E. ; Henry Raymond L., Medical uses of in situ formed gels.
  107. Viegas Tacey X. ; Reeve Lorraine E. ; Henry Raymond L., Medical uses of in situ formed gels.
  108. Pinedjian, Raffi S., Method and apparatus for drug delivery.
  109. Reeve Lorraine E. ; Flore Stephen G., Method and composition for inhibiting post-surgical adhesions.
  110. Raymond L. Henry ; Lorraine E. Reeve ; Stephen G. Flore ; Frederick J. Foley, Method and non-gelling composition for inhibiting post-surgical adhesions.
  111. Sheffield Warren D. (Lebanon NJ) Johns Douglas B. (Milford NJ) Shalaby Shalaby W. (Lebanon NJ) diZerega Gere S. (Pasadena CA) Richer LeRoy L. (San Gabriel CA), Method for inhibiting post-surgical adhesion formation by the topical administration of non-steroidal anti-inflammatory.
  112. Viegas Tacey X. (Canton MI) Reeve Lorraine E. (Dexter MI) Henry Raymond L. (St. Clair Shores MI), Method of making thermoreversible polyoxyalkylene gels.
  113. Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
  114. Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
  115. Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
  116. Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
  117. Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
  118. Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
  119. Campbell, Phil G.; Burgess, James E.; Weiss, Lee E.; Smith, Jason, Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom.
  120. Flore Stephen G. ; Dellamary Luis A. ; Reeve Lorraine E. ; Weers Jeffry G., Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions.
  121. Trom Matt C. ; Oxman Joel D., Methods of etching hard tissue in the oral environment.
  122. Oxman Joel D. ; Trom Matt C., Methods of whitening teeth.
  123. Masters, David B.; Berg, Eric P., Mucoadhesive drug delivery devices and methods of making and using thereof.
  124. Dos Santos, Cesario Pereira, Multi-layer heat assembly for a drug delivery device.
  125. Dos Santos, Cesario Pereira; Gelvin, Michael LeRoy, Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device.
  126. Dacquay, Bruno; Lind, Casey; Dos Santos, Cesario; Sanchez, Jr., Robert J, Ophthalmic injection device including dosage control device.
  127. Dacquay, Bruno; Lind, Casey; Martin, Mike, Ophthalmic injection device using piezoelectric array.
  128. Dacquay, Bruno; Lind, Casey; Martin, Mike, Ophthalmic injection device using shape memory alloy.
  129. Dacquay, Bruno; Dos Santos, Cesario; Foster, James; Sanchez, Robert, Ophthalmic injection method.
  130. Dacquay, Bruno; Dos Santos, Cesario; Foster, James; Lind, Casey; Pinedjian, Raffi; Sanchez, Robert, Ophthalmic injection system.
  131. Robert, Glick; Daniel, Brady, Ophthalmic lens combinations.
  132. Dobrozsi,Douglas Joseph; Hayes, II,Jerry William; Bealin Kelly,Francis Joseph David; Khanolkar,Jayant Eknath; Mullet,Benoit Maurice; DE LA Harpe,Shane Michael; Robbins,Brian James, Orally administered liquid compositions.
  133. Kabanov Alexander V. ; Alakhov Valery Y.,CAX, Peptide copolymer compositions.
  134. Alexander Victorovich Kabanov ; Valery Yulievich Alakov CA; Sergey V. Vingogradov, Polynucleotide compositions.
  135. Kabanov Alexander V. ; Alakov Valery Y.,CAX ; Vinogradov Sergey V., Polynucleotide compositions.
  136. Dobrozsi, Douglas Joseph; Hayes, II, Jerry William; Lindman, Bjorn Olof; Ivanova, Rouja Hristova; Alexandridis, Paschalis, Pourable liquid vehicles.
  137. Brady, Daniel G.; Woods, Randall L.; Bumbalough, Timothy R.; Geraghty, Edward P., Pre-stressed haptic for accommodating intraocular lens.
  138. Cohen Jonathan M. (Matawan NJ) Berry Ira R. (Westfield NJ) Borkan Lionel (New Vernon NJ), Preparation of gelatin-encapsulated controlled release composition.
  139. KC, Sunil Kumar, Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo [4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide.
  140. Masters, David B., Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof.
  141. Masters, David B.; Berg, Eric P., Protein biomaterials and biocoacervates and methods of making and using thereof.
  142. Masters, David B.; Berg, Eric P., Protein biomaterials and biocoacervates and methods of making and using thereof.
  143. Masters, David B., Protein matrix materials, devices and methods of making and using thereof.
  144. Masters, David B., Protein matrix materials, devices and methods of making and using thereof.
  145. Himmelstein Kenneth J. (Omaha NE) Baustian Cara L. (Pearl River NY 4), Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use.
  146. Pinedjian, Raffi; Sanchez, Jr., Robert J., Spring driven ophthalmic injection device with safety actuator lockout feature.
  147. Vacanti, Martin P.; Vacanti, Charles A., Subpopulations of spore-like cells and uses thereof.
  148. Vacanti, Martin P.; Vacanti, Charles A., Subpopulations of spore-like cells and uses thereof.
  149. Vacanti, Martin P.; Vacanti, Charles A., Subpopulations of spore-like cells and uses thereof.
  150. Vacanti, Martin P.; Vacanti, Charles A., Subpopulations of spore-like cells and uses thereof.
  151. Daniel C. Rosenman, System and method for delivering thermally sensitive and reverse-thermal gelation materials.
  152. Rosenman, Daniel C., System and method for delivering thermally sensitive and reverse-thermal gelation materials.
  153. Rosenman,Daniel C., System and method for delivering thermally sensitive and reverse-thermal gelation materials.
  154. Dos Santos, Cesario; Sanchez, Jr., Robert J., Temperature control device and thermal sensor assembly for medical device.
  155. Dacquay, Bruno; Santos, Cesario Dos; Lind, Casey, Temperature release mechanism for injection device.
  156. Lewis P. Stratton ; John F. Carpenter ; Mark C. Manning, Temperature sensitive gel for sustained delivery of protein drugs.
  157. Stratton Lewis P. ; Carpenter John F. ; Manning Mark C., Temperature sensitive gel for sustained delivery of protein drugs.
  158. Olivieri,Laetitia; Ron,Eyal S., Thermally reversible water in oil in water emulsions.
  159. Kabra Bhagwati P. (Fort Worth TX) Lang John C. (Arlington TX), Thermally-gelling drug delivery vehicles containing cellulose ethers.
  160. Wolfgang Neuberger MY; Patrice Thierry FR, Treatment for Barrett's syndrome.
  161. Masters, David B.; Berg, Eric P., Wound treatments with crosslinked protein amorphous biomaterials.
  162. Kumar KC, Sunil; Wallace, David Mark; Hood, John; Barroga, Charlene F., β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators.
  163. KC, Sunil Kumar; Wallace, David Mark; Hood, John; Barroga, Charlene F., β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activators.
  164. Kumar KC, Sunil; Wallace, David Mark; Hood, John; Barroga, Charlene F., β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activators.
  165. Kumar KC, Sunil; Wallace, David Mark; Hood, John; Barroga, Charlene F., β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators.
  166. Kumar KC, Sunil; Wallace, David Mark; Hood, John; Barroga, Charlene F., γ-diketones as WNT/β-catenin signaling pathway activators.
  167. KC, Sunil Kumar; Wallace, David Mark; Hood, John; Barroga, Charlene F., γ-diketones as Wnt/β-catenin signaling pathway activators.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로